Search the Community
Showing results for tags 'gene therapy'.
Found 2 results
FDA Grants Fast Track Status to Fibrocell's Gene Therapy FCX-013 for Localized Scleroderma. Fibrocell Science's gene therapy candidate FCX-013 received fast track designation by the U.S. Food and Drug Administration as a treatment for moderate––to–severe localized scleroderma. Scleroderma News, 09/06/2018. (Also see Clinical Trials) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
Companies Rush to Develop ‘Utterly Transformative’ Gene Therapies. The approval of gene therapy for leukemia, expected in the next few months, will open the door to a radically new class of cancer treatments. New York Times, 07/23/2017. (Also see Cancer) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.